Abstract
Purpose
This retrospective study reports the intermediate-term clinical outcomes including the practical function in daily and sports activities after total ankle arthroplasty for end-stage rheumatoid arthritis, as well as the effects of modification of perioperative anti-rheumatic medications.
Materials and Methods
Twelve patients were followed for a minimum of 2 years after total ankle replacement for end-stage rheumatoid arthritis. Perioperative anti-rheumatic medications in all patients were modified based on a specific guideline. Clinical evaluations consisted of American Orthopaedic Foot and Ankle Society (AOFAS) scores, Foot and Ankle Outcome Score (FAOS), and Foot and Ankle Ability Measure (FAAM) scores. Periodic radiographic evaluation was conducted to detect changes in ankle alignment and postoperative complications.
Results
Mean AOFAS, FAOS, and FAAM scores improved significantly from 37.5 to 81.2, 39.1 to 72.4, and 33.8 to 64.0 points at final follow-up, respectively (p<0.001). Functional outcomes in daily and sports activities at final follow-up were found to be 76.5 and 55.8 points for the FAOS and 70.5 and 57.5 points for the FAAM, respectively. As early postoperative complications, there was one case of local wound necrosis, one case of medial malleolar fracture, and one case of deep peroneal nerve injury. Radiological evaluation revealed two cases of asymptomatic heterotopic ossification and one case of progressive arthritis in the talonavicular joint. Reoperation was performed in only one patient (8.3%) with a medial soft tissue impingement at a mean of 35.6 months follow-up.
Conclusion
Total ankle arthroplasty appears to be an effective surgical option for end-stage rheumatoid arthritis. Practical functions in daily and sports activities were significantly improved at intermediate-term follow-up. Modification of perioperative anti-rheumatic medications can be one of the solutions to reduce the postoperative complication rate.
Figures and Tables
References
2. Ahmad J, Raikin SM. Ankle arthrodesis: the simple and the complex. Foot Ankle Clin. 2008; 13:381–400. DOI: 10.1016/j.fcl.2008.04.007.
3. Morash J, Walton DM, Glazebrook M. Ankle arthrodesis versus total ankle arthroplasty. Foot Ankle Clin. 2017; 22:251–266. DOI: 10.1016/j.fcl.2017.01.013.
4. Pedowitz DI, Kane JM, Smith GM, Saffel HL, Comer C, Raikin SM. Total ankle arthroplasty versus ankle arthrodesis: a comparative analysis of arc of movement and functional outcomes. Bone Joint J. 2016; 98-B:634–640. DOI: 10.1302/0301-620X.98B5.36887.
5. Singer S, Klejman S, Pinsker E, Houck J, Daniels T. Ankle arthroplasty and ankle arthrodesis: gait analysis compared with normal controls. J Bone Joint Surg Am. 2013; 95:e191(1-10). DOI: 10.2106/JBJS.L.00465.
6. Guyer AJ, Richardson G. Current concepts review: total ankle arthroplasty. Foot Ankle Int. 2008; 29:256–264. DOI: 10.3113/FAI.2008.0256.
7. Doets HC, Brand R, Nelissen RG. Total ankle arthroplasty in inflammatory joint disease with use of two mobile-bearing designs. J Bone Joint Surg Am. 2006; 88:1272–1284. DOI: 10.2106/JBJS.E.00414.
8. den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol. 2007; 34:689–695.
9. Sindhu K, Cohen B, Gil JA. Perioperative management of rheumatoid medications in orthopedic surgery. Orthopedics. 2017; 40:282–286. DOI: 10.3928/01477447-20170518-04.
10. Stengel D, Bauwens K, Ekkernkamp A, Cramer J. Efficacy of total ankle replacement with meniscal-bearing devices: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2005; 125:109–119. DOI: 10.1007/s00402-004-0765-3.
11. Dougherty CD, Hung YY, Weintraub MLR, Patel S, King CM. Osseous and soft tissue complications associated with foot and ankle surgery in patients with rheumatoid arthritis taking a variety of antirheumatic medications. J Foot Ankle Surg. 2019; 58:508–513. DOI: 10.1053/j.jfas.2018.09.030.
12. Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014; 66:254–263. DOI: 10.1002/art.38231.
13. Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. J Arthroplasty. 2017; 32:2628–2638. DOI: 10.1016/j.arth.2017.05.001.
14. Hintermann B, Valderrabano V, Dereymaeker G, Dick W. The HINTEGRA ankle: rationale and short-term results of 122 consecutive ankles. Clin Orthop Relat Res. 2004; (424):57–68. DOI: 10.1097/01.blo.0000132462.72843.e8.
15. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001; 358:903–911. DOI: 10.1016/S0140-6736(01)06075-5.
16. Somayaji R, Barnabe C, Martin L. Risk factors for infection following total joint arthroplasty in rheumatoid arthritis. Open Rheumatol J. 2013; 7:119–124. DOI: 10.2174/1874312920131210005.
17. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001; 60:214–217. DOI: 10.1136/ard.60.3.214.
18. Diaper R, Wong E, Metcalfe SA. The implications of biologic therapy for elective foot and ankle surgery in patients with rheumatoid arthritis. Foot (Edinb). 2017; 30:53–58. DOI: 10.1016/j.foot.2017.01.009.
19. Weinreb JH, Cote MP, O'Sullivan MB, Mazzocca AD. Shoulder arthroplasty: disposition and perioperative outcomes in patients with and without rheumatoid arthritis. Am J Orthop (Belle Mead NJ). 2016; 45:E204–E210.
20. Newton SE 3rd. Total ankle arthroplasty. Clinical study of fifty cases. J Bone Joint Surg Am. 1982; 64:104–111.
21. Ng SY, Crevoisier X, Assal M. Total ankle replacement for rheumatoid arthritis of the ankle. Foot Ankle Clin. 2012; 17:555–564. DOI: 10.1016/j.fcl.2012.08.004.
22. Jeong BO, Jung H. Severe ankle osteoarthritis: treatment with total ankle arthroplasty. J Korean Foot Ankle Soc. 2018; 22:8–15. DOI: 10.14193/jkfas.2018.22.1.8.
23. Anderson T, Montgomery F, Carlsson A. Uncemented STAR total ankle prostheses. Three to eight-year follow-up of fifty-one consecutive ankles. J Bone Joint Surg Am. 2003; 85:1321–1329. DOI: 10.2106/00004623-200307000-00019.
24. Althoff A, Cancienne JM, Cooper MT, Werner BC. Patient-related risk factors for periprosthetic ankle joint infection: an analysis of 6977 total ankle arthroplasties. J Foot Ankle Surg. 2018; 57:269–272. DOI: 10.1053/j.jfas.2017.09.006.
25. Kofoed H, Sørensen TS. Ankle arthroplasty for rheumatoid arthritis and osteoarthritis: prospective long-term study of cemented replacements. J Bone Joint Surg Br. 1998; 80:328–332. DOI: 10.1302/0301-620X.80B2.0800328.
26. Valderrabano V, Pagenstert G, Horisberger M, Knupp M, Hintermann B. Sports and recreation activity of ankle arthritis patients before and after total ankle replacement. Am J Sports Med. 2006; 34:993–999. DOI: 10.1177/0363546505284189.
27. Kim BS, Knupp M, Zwicky L, Lee JW, Hintermann B. Total ankle replacement in association with hindfoot fusion: outcome and complications. J Bone Joint Surg Br. 2010; 92:1540–1547. DOI: 10.1302/0301-620X.92B11.24452.
28. Fevang BT, Lie SA, Havelin LI, Brun JG, Skredderstuen A, Furnes O. 257 ankle arthroplasties performed in Norway between 1994 and 2005. Acta Orthop. 2007; 78:575–583. DOI: 10.1080/17453670710014257.
29. San Giovanni TP, Keblish DJ, Thomas WH, Wilson MG. Eight-year results of a minimally constrained total ankle arthroplasty. Foot Ankle Int. 2006; 27:418–426. DOI: 10.1177/107110070602700606.
30. Gougoulias N, Khanna A, Maffulli N. How successful are current ankle replacements?: a systematic review of the literature. Clin Orthop Relat Res. 2010; 468:199–208. DOI: 10.1007/s11999-009-0987-3.